Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MORNING BID-Asking for more stimulus?

Wed, 08th Jul 2020 09:04

* A look at the day ahead from EMEA deputy markets editor
Sujata
Rao. The views expressed are her own

LONDON, July 8 (Reuters) - Share markets are wavering after
snapping a five-day winning streak on Tuesday when world stocks
tumbled 1% and all three U.S. indexes closed in the red.

This morning, Wall Street futures and European equities are
both lower, Treasury yields are close to the one-week lows they
plumbed on Tuesday and German yields are 2 basis points lower.
China's Shanghai and Shenzhen benchmarks continued to march
higher in what's widely seen as a state-sanctioned rally.

In keeping with the jittery mood, the dollar is holding firm
as is gold. The Chinese rally has stoked demand for commodities,
pushing Shanghai copper to its highest in more than a year.
Chinese equity gains – the seventh day in a row – also pushed
emerging equities 0.7% higher.

The most obvious explanation for the pullback is the rise in
U.S. coronavirus cases, with 3 million confirmed cases and
localised activity restrictions. Atlanta Fed President Rafael
Bostic said there was a real sense the coronavirus crisis "might
go on longer than we have planned for".

Criticism of U.S President Donald Trump's handling of the
crisis is seen damaging his re-election chances, forcing Wall
Street to contend with the possibility of a Democrat
administration, higher taxes and tighter regulation.

Markets may also be hankering after another dose of stimulus
– Fed Vice Chair Richard Clarida said there was no limit to how
much bond buying the Fed could do.

The Cleveland Fed's Loretta Mester, meanwhile, called for
more help from the fiscal side. She may have hit the nail on the
head -- there's some unease as the scheme to supplement U.S.
jobless payments expires at the end of July just as the COVID-19
spike threatens to derail new hiring.

Consultancy Oxford Economics points out the worsening
coronavirus comes just as liquidity provision from central banks
and governments is slowing – central banks' balance-sheet growth
isn't accelerating any more, while some governments seem wary of
further fiscal measures that risk adding to debt.

Barclays said this morning in its annual equity-gilt study
that while all the extra borrowing is needed, deficits will need
to be addressed some day, with higher taxes part of the
solution.

Speaking of fiscal stimulus, British finance minister Rishi
Sunak is expected to announce measures to counter the jump in
unemployment. Aside from spending 3 billion pounds to improve
energy efficiency, he could announce VAT cuts, lower property
purchases taxes and vouchers to aid hospitality businesses. The
pound is holding near three-week highs before his speech.

In European corporate news, AstraZeneca and Merck &
Co said their cancer treatment Lynparza won European
Union approval for treating a form of pancreatic cancer.

Shares in Traton were down 3.6% after the company
announced management changes. Deutsche Post
was up 1.3% after reporting a 16% rise in
second-quarter operating profit.

In coronavirus-linked bad news, logistics company DHL may
cut as many as 2000 UK jobs, the Unite trade union said;
FirstGroup warned on its ability to continue as a going
concern, after posting an annual operating loss and plunging
passenger volumes; OMV second-quarter output dropped
5% in wake of coronavirus pandemic.

In emerging markets, China's yuan is near 7 to the dollar
after briefly breaking through the threshold on Tuesday.
Nigeria' naira fell 5.5% on Tuesday following central bank FX
sales at a lower rate -- possibly after pressure from lenders
and markets to unify its plethora of exchange rates.

Non-deliverable forwards see the naira losing a fifth of its
value over the next 12 months.
(Editing by Larry King
)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.